Skip to main content

Table 3 Univariate and Multivariate analysis of preoperative variables predicting one-year mortality

From: Predictors of mortality within the first year post-hepatectomy for hepatocellular carcinoma

n = 163 Univariate
analysis
Multivariate
analysis
p value HR (95% CI) p value HR (95% CI)
Body mass index > 27 0.297 0.039 (0.000–17.449)   
Age > 60 years 0.133 0.453 (0.161–1.272)   
Sex 0.257 0.037 (0.000–11.176)   
Hepatitis B 0.671 0.803 (0.291–2.213)   
Hepatitis C 0.584 0.568 (0.075–4.317)   
Hemoglobin < 10g/dL 0.402 2.380 (0.313–18.110)   
Platelet < 150 × 109/L 0.986 0.989 (0.279–3.504)   
Albumin < 35 g/L 0.064 2.656 (0.945–7.466) 0.453 0.549 (0.114–2.633)
Prognostic nutritional index < 45 0.021 3.545 (1.211–10.375) 0.103 2.974 (0.802–11.030)
Platelet/lymphocyte ratio ≥ 150 0.089 2.412 (0.875–6.652) 0.189 2.112 (0.692–6.447)
Neutrophil/lymphocyte ratio ≥ 5 0.038 3.368 (1.072–10.585) 0.839 0.855 (0.188–3.881)
Alpha-fetoprotein ≥ 1000 ng/mL 0.244 1.973 (0.628–6.198)   
Tumor (≥ 10 cm) 0.469 1.526 (0.486–4.794)   
Tumor (≥ 5 cm) 0.147 2.149 (0.765–6.037)   
Bilirubin > 31 μmol/L 0.531 0.046 (0.000–710.247)   
Child-Pugh B/C 0.004 4.941 (1.685–14.491) 0.035 5.479 (1.130–26.551)
American Society of Anesthesiology score (ASA) > 2 0.319 1.727 (0.590–5.052)   
Eastern Cooperative Oncology Group (ECOG) > 1 0.726 1.437 (0.189–10.930)   
Tumors (≥ 2) 0.001 5.897 (2.105–17.262) 0.001 7.105 (2.305–21.899)
  1. CI Confidence interval